Cibus stock plunges to 52-week low at $2.36 amid market challenges By Investing.com

In a turbulent market environment, shares of Cibus Global Ltd. (CBUS) fell to a 52-week low of just $2.36, which is significantly lower than the 52-week high of $23.18, reflecting a sharp 1-year decline change, when the stock value fell sharply by -88.48% InvestingPro: analysis, analysts’ price targets range from $4 to $25, suggesting potential upside despite ongoing challenges The sharp decline highlights the broader pressures facing the industry and raises questions about the company’s strategy going forward. InvestingPro: The data shows the company’s weak financial health at 1.65 with a rapid cash burn and negative EBITDA of -$60.3 million over the last twelve months.For more in-depth insights, including 13 additional ProTips and comprehensive analysis, explore Pro Research- s full report available on InvestingPro.

In other recent news, Cibus Inc. unveiled a new base salary for CEO Carlo Bruce, a move that follows significant revenue growth at Cibus over the past year, but the company remains loss-making. Meanwhile, Jefferies adjusted its price target on Cibus to $5.00 from $8.00, while maintaining a Hold rating on the stock.

Despite the financial losses, Cibus has made progress in its agricultural gene-editing technologies, including the successful development of its Trait Machine process.

In the coming years, Cibus plans to launch Pesticide Resistant and Pod Shatter Reduction properties, targeting significant market opportunities in various regions. The company is also exploring sustainable ingredients and fragrances, with announcements expected next year efforts to increase agricultural productivity and sustainability through gene editing.

This article is powered by AI and has been reviewed by an editor. See our T&C for more information.